Companies:

 

Articles:

 

Stock summary

Companies:

 

Clarity Pharmaceuticals Ltd (ASX: CU6)

 
Service provided by WebLinkIR

Company news

Cover Image for Clarity Pharmaceuticals gains FDA fast-track status for advanced prostate cancer imaging drug

Clarity Pharmaceuticals gains FDA fast-track status for advanced prostate cancer imaging drug

Cover Image for Clarity Pharmaceuticals begins phase II trial using SAR-Bombesin as prostate cancer diagnostic

Clarity Pharmaceuticals begins phase II trial using SAR-Bombesin as prostate cancer diagnostic